A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...

Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.

An international clinical trial shows an innovative CAR-T cell immunotherapy is promising against aggressive T cell cancers and has manageable side effects.

B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...

Highlights in acute lymphoblastic leukemia (ALL), presented at the American Society of Hematology (ASH) 2024 Annual Meeting and Exposition, include studies on pediatric and adult disease ...

Association Between Travel Distance and Metastatic Disease at Diagnosis Among Patients With Colon Cancer Prospective brain magnetic resonance imaging was performed at four time points for 369 children ...

The treatment of leukemia among children could be made more precise with fewer side effects with the help of more accurate ...

Persistent racial disparities in AML survival in the FLT3 inhibitor era. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component.

Imagine helping save a child’s life — just by buying a ticket to win a brand-new home. That’s the idea behind the st. Jude dream home giveaway.When ethan washbu ...

EMA grants conditional marketing authorization to Autolus’ Aucatzyl to treat adults with acute lymphoblastic leukaemia: Amsterdam, The Netherlands Monday, May 26, 2025, 16:00 Hr ...